Prostate Cancer Podcast – Is Prostate Cancer Inherited?
Family history and genetics. Prostate cancer is often referred to as a family disease. Is it and what does this actually mean? Malecare's Advanced Prostate Cancer Program Director, Joel Nowak, interviews Dr. Lorelei A. Mucci. Dr. [...]
An Independent Prognostic Tool For Men With Metastatic Castrate Resistant Prostate Cancer Taking The Newer Drugs
We have a number of newer hormone pathway drugs now available to treat men with metastatic castrate resistant prostate cancer (mCRPC). Researchers have shown that prostate specific antigen (PSA) response can be used as a [...]
Early Hormone Therapy In Men With A Rising PSA Live Longer Then Men Who Delay Therapy – A Phase 3 Trial
The standard of care is to offer androgen deprivation therapy (ADT) to men with prostate cancer who have a rising prostate specific antigen (PSA) after an attempt to cure their cancer with primary therapy that [...]
Short Term Androgen Therapy Might Be Better For More Aggressive Gleason Grade Prostate Cancer
In a recently published commentary about the optimal type of multi-modal hormone therapy for Gleason grade 4 and 5 prostate cancer the author addressed the discordance between results of several randomized trials evaluating survival benefit [...]
New Markers To Make Better Treatment Decisions For Prostate Cancer
Making treatment decisions once you have been diagnosed with prostate cancer is difficult. Often, it is impossible to accurately and reliably be able to predict the eventual course of the cancer. Prostate cancer, besides being [...]
Prior Radiation Exposure Should Not Effect The Outcomes Derived From The Implantation Of An Artificial Urinary Sphincter
The possibility of having incontinence as a side effect from all of the primary prostate cancer treatments is significant. Incontinence is not an either or thing as the degree of incontinence varies from individual to [...]